Iatrogenic Cutaneous Kaposi Sarcoma Associated with Chronic Corticosteroid Therapy
EUROPEAN JOURNAL OF CASE REPORTS AND CLINICAL IMAGES · 01.01.2026 · 02 (02) · 01
DOI: 10.51521/ejcrci.2026.e22.116 ↗Kurz gefasst
Fachartikel in der Zeitschrift EUROPEAN JOURNAL OF CASE REPORTS AND CLINICAL IMAGES, online erschienen am 01.01.2026. Verfasst von Sara Tereso und 1 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
A 76-year-old man with polymyalgia rheumatica on prednisolone presented with erythematous violaceous maculopapules on the lower limbs, which did not blanch on digital pressure, were non pruritic, non-bleeding and painless, under outpatient follow up. Due to an increase in the number of these lesions on the lower limbs, with extension to the left upper limb (Figures 1 and 2), reaching a maximum diameter of 2 cm, hospital observation was warranted. Physical examination revealed no mucosal involvement and no palpable lymphadenopathies. Laboratory tests showed negative serologies for HIV, EBV, syphilis and hepatitis B/C, excluding other causes of immunodeficiency. Cervical, thoracic, abdominal and pelvic computed tomography revealed no abnormalities. Skin biopsy demonstrated a perivascular lymphocytic infiltrate with scattered plasma cells in the dermis and proliferation of irregular and asymmetric blood vessels. Immunohistochemistry was positive for human herpesvirus type 8 (HHV 8). Based on the clinical and histological findings, and after excluding differential diagnoses, a diagnosis of iatrogenic cutaneous Kaposi’s sarcoma in the context of chronic corticosteroid therapy was established. Corticosteroid therapy was reduced, with improvement and progressive regression of the lesions. Kaposi’s sarcoma is a rare angioproliferative tumour, [1,2] typically cutaneous, [3] with either indolent or aggressive behaviour, in which HHV 8 plays a central role in its pathogenesis [1,3,4] and can be detected in all its variants [4]. HHV 8, associated with states of immunosuppression such as rheumatological disease treated with corticosteroids, may induce Kaposi’s sarcoma [4,5]. Lesions may range from macules and plaques to violaceous exophytic tumours, [1,2] potentially invading adjacent tissues, and discontinuation of the immunosuppressive drug is recommended [5].
Zitieren
APA
Tereso, S., & Costa, C. M. E. (2026). Iatrogenic Cutaneous Kaposi Sarcoma Associated with Chronic Corticosteroid Therapy. EUROPEAN JOURNAL OF CASE REPORTS AND CLINICAL IMAGES, 02(02), 01. https://doi.org/10.51521/ejcrci.2026.e22.116
Vancouver
Tereso S, Costa CME. Iatrogenic Cutaneous Kaposi Sarcoma Associated with Chronic Corticosteroid Therapy. EUROPEAN JOURNAL OF CASE REPORTS AND CLINICAL IMAGES. 2026;02(02):01. doi:10.51521/ejcrci.2026.e22.116
BibTeX
@article{Tereso2026,
author = {Tereso, Sara and Costa, Carlos Machado e},
title = {Iatrogenic Cutaneous Kaposi Sarcoma Associated with Chronic Corticosteroid Therapy},
journal = {EUROPEAN JOURNAL OF CASE REPORTS AND CLINICAL IMAGES},
year = {2026},
volume = {02},
number = {02},
pages = {01},
doi = {10.51521/ejcrci.2026.e22.116}
}
EUVIMED